Kristina Bauer-Maas

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Peri-transplant ruxolitinib prophylaxis improves outcome in patients receiving allogeneic hematopoietic cell transplantation for myelofibrosis.

Peri-transplant ruxolitinib prophylaxis improves outcome in patients receiving allogeneic hematopoietic cell transplantation for myelofibrosis.

Journal: Transplantation and cellular therapy

Published: May 08, 2026

Peri-Transplant Ruxolitinib Prophylaxis Improves Outcome in Patients Receiving Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.

Peri-Transplant Ruxolitinib Prophylaxis Improves Outcome in Patients Receiving Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis.

Journal: Transplantation and cellular therapy

Published: May 08, 2026

Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: April 27, 2026

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors.

Journal: Annals of hematology

Published: December 13, 2025

Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation.

Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation.

Journal: Frontiers in immunology

Published: November 13, 2025

The iNKT-Treg axis in GVHD control.

The iNKT-Treg axis in GVHD control.

Journal: Blood

Published: October 23, 2025

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation.

Journal: Bone marrow transplantation

Published: September 19, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Gastrin for the treatment of acute graft-versus-host disease of the stomach.

Journal: Blood

Published: August 01, 2025

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study.

Influence of daytime of allogeneic stem cell transplantation on incidence of acute graft vs. host disease: a retrospective analytical cohort study.

Journal: Bone marrow transplantation

Published: May 07, 2025

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML.

Journal: Blood

Published: April 24, 2025

The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation.

The importance of systemic inflammatory response measurements as pretransplant risk factors for outcome after allogeneic haematopoietic cell transplantation.

Journal: British journal of haematology

Published: February 18, 2025

Showing 1-12 of 29

Last Updated: 09/26/2026